Accepted Articles

IJL 2023 34: Chadox1-S/Ncov-19 vaccine induced type 1 lepra reaction in patient of borderline lepromatous leprosy (letter to editor).

  • Corresponding Author: Dr Astha Arora
  • Status: Accepted

IJL 2023 26: Letter regarding published article entitled “Versatile Use of Mycobacterium indicus pranii (MIP) vaccine by Thangaraju et al” (letter to editor);

  • Corresponding Author: Dr Rakesh Bharti;
  • Status: Accepted

IJL 2023 24: Current practice and challenges with the use of multidrug therapy (MDT) in the management of pediatric leprosy patients: an expert perspective from India;

  • Corresponding Author: Dr Sunil Modali
  • Status: Accepted

IJL 2023 20: Comment on “Case Report: Father-Daughter Duo: How Unmasking Leprosy in Father Helped in Leprosy Diagnosis in the Daughter - A Case Report” (letter to editor);

  • Corresponding Author: Dr Tarun Narang
  • Status: Accepted

IJL 2023 16: The Leprosy Care Cadre Tracking (KETAPEL) model with social learning theory approach increases the leprosy new case detection;

  • Corresponding Author: Dr Kurniadi;
  • Status: Accepted

IJL 2023 15: Assessment of mental well-being and quality of life in the context of disability in leprosy patients,

  • Corresponding Author: Roshni M Mathew
  • Status: Accepted

IJL 2023 14: Current leprosy burden: India should lead the way ( letter to editor);

  • Corresponding Author: Dr NK Das
  • Status: Accepted

IJL 2023 11: Necrotic erythema nodosum leprosum in a borderline lepromatous patient diagnosed as disseminated phaeohyphomycosis;

  • Corresponding Author: Dr S Pradeep Nair;
  • Status: Accepted

IJL 2023 07: Clinico-epidemiological profile of leprosy in the light of leprosy eradication: Achieved or still a dream;

  • Corresponding Author: Dr Vijay Paliwal
  • Status: Accepted

IJL 2023 02: Decadal análisis of childhood leprosy trends: A study of cases in a South Indian tertiary care centre;

  • Corresponding Author: Dr NA Paul
  • Status: Accepted

IJL 2022 40: A clinico-epidemiological profile of lepra reactions in north India from tertiary care hospital in post elimination era;

  • Corresponding Author: Dr DeepikaYadav
  • Status: Accepted

IJL 2022-36: Title: A descriptive, cross-sectional study on epidemiological factors of newly registered leprosy patients for 5 years in the tertiary health care centre in central Tamilnadu;

  • Corresponding Author: Dr Narmadha
  • Status: Accepted

IJL 2022-22: Burden of Hansen’s disease in tertiary care hospital of north east India : A retrospective study of ten years;

  • Corresponding Author: Dr Loknandini Sharma
  • Status: Accepted

IJL 2023 08 : Response to The Combination Therapy of Oral Steroids and Nerve Decompression for Ulnar Neuritis in Leprosy - Usefulness in Prevention of Progression of Hand Deformities (Letter to Editor).

  • Corresponding Author: Dr Tarun Narang
  • Status: Accepted

IJL 2022 41: Spectrum of Leprosy At a Tertiary Care Neurology Center In India with: a Suggestion To Monitor The Outcome,

  • Corresponding Author: Dr UK Misra
  • Status: Accepted

IJL 2022-35: Autologous Subcutaneous Platelet-rich Palsma in the Management of Non-Healing Trophic Ulcer in Leprosy.

  • Corresponding Author: Dr Shagufta Rather
  • Status: Accepted

IJL 2022-34: Socio-psychological Issues of Adolescents Affected with Leprosy: A Scoping Review.

  • Corresponding Author: Dr Shahnawaz
  • Status: Accepted

IJL 2022-32: A retrospective study profile on leprosy in the paediatric population between 2017-2021 in a tertiary care hospital in north Chennai.

  • Corresponding Author: Dr Lakshmi
  • Status: Accepted

IJL 2022-31: Dehabilitaion among leprosy affected persons and lived experiences: a mixed-method study.

  • Corresponding Author: Dr Anupum Gupta
  • Status: Accepted

IJL 2022 30 : Case Series, Histoid Leprosy: Are we harbouring potential community menace post elimination era in India – a case series,

  • Corresponding Author: Dr Loknandini Sharma
  • Status: Accepted

IJL 2022-29 : Hansen's disease: still a burden in post elimination era..

  • Corresponding Author: Dr Praveena C
  • Status: Accepted

IJL 2022-27: A rare case of leprous macrocheilia in Borderline tuberculoid leprosy with type 1 reaction.

  • Corresponding Author: Dr Disha Chakraborty
  • Status: Accepted

IJL 2022-26: A case series of Histoid Leprosy with a brief comparison of the clinical features with that of lepromatous leprosy..

  • Corresponding Author: Dr Pradeep Nair
  • Status: Accepted

IJL 2022- 19: Leprosy Skin Lesion Detection: An AI approach Using Few Shot Learningin a Small Clinical Dataset.

  • Corresponding Author: Dr Ramakanteswara Beesetty
  • Status: Accepted

IJL 2022-28: Analysis of the Incidence of Leprosy in the Northeast Region of Brazil: 2011 to 2021

  • Corresponding Author: Dr DG Kramer
  • Status: Accepted

IJL 2022-23 : Spatial distribution of leprosy cases notified in a reference center in the municipality of Várzea Grande – MT

  • Corresponding Author: Dr Vanessa Matias Souza Duarte
  • Status: Accepted

IJL 2022- 18: A case of Dysphonia turned out to be lepromatous leprosy with laryngeal involvement

  • Corresponding Author: Dr. Ashwini Handal
  • Status: Accepted

IJL 2022 16: Risk factors for erythema nodosum leprosum : A case control study in a tertiary hospital at western Odisha, India

  • Corresponding Author: Dr Debabrata Nayak
  • Status: Accepted

IJL 2022- 15: Milia Over Healing Leprosy Plaque: A Rare Presentation

  • Corresponding Author: Dr Iti Varshney
  • Status: Accepted

IJL 2022- 14: Unmasking leprosy: father-daughter duo case

  • Corresponding Author: Dr Foram Amish Parikh
  • Status: Accepted

IJL 2022- 12: Study Of Correlation Of High Resolution Ultrasonography and Ultrasonography Guided Fine Needle Aspiration Cytology In Diagnosis Of Pure Neuritic Leprosy In A Tertiary Care Hospital

  • Corresponding Author: Dr Dipti Ranjan Bisoyi
  • Status: Accepted

IJL 2022- 11: Response to Case Report: De-Novo Ulcero-Necrotic Presentation of Untreated Leprosy

  • Corresponding Author: Dr S Dogra
  • Status: Accepted

IJL 2022- 07: Role of Interleukin-10 in Leprosy: A Review

  • Corresponding Author: Dr Irsan Saleh
  • Status: Accepted

IJL 2022- 06 : Sensory ganglionopathy in Hansen’s disease: Report of a patient and review of literature

  • Corresponding Author: Dr Jayantee Kalita
  • Status: Accepted

IJL2022 04: Localized sensory loss following chikungunya infection

  • Corresponding Author: Dr Nithya Satish
  • Status: Accepted

IJL 2022- 08: Sole, an uncommon location of borderline tuberculoid Hansen’s

  • Corresponding Author: Dr Surina Nair
  • Status: Accepted

IJL 2022- 05: Histoid Hansen’s presenting with borderline tuberculoid lesions in reaction

  • Corresponding Author: Dr Niharika Dhattarwal
  • Status: Accepted

IJL 2022- 01: Clinico-epidemiological trends of leprosy in 21st and during COVID 19 pandemic

  • Corresponding Author: Dr Sandhya Kumari
  • Status: Accepted

2021- 61 : Mycobacterium indicus pranii vaccine: a jack of all trades

  • Corresponding Author: Dr T Pugazhenthan
  • Status: Accepted

IJL 2021 – 49 : Attitude of People Affected with Leprosy towards Fellow People Affected with Leprosy in an Endemic District, West Bengal, India

  • Corresponding Author: Dr. G Pitchaimani
  • Status: Accepted

IJL 2022-37: Leprosy : the Origin of the Concept of Psychological Burnout

  • Corresponding Author: Dr Carlos Franco-Paredes
  • Status: Accepted